Author Question: An older adult man has moved to a long-term care facility and the nurse is performing a medication ... (Read 57 times)

asmith134

  • Hero Member
  • *****
  • Posts: 576
An older adult man has moved to a long-term care facility and the nurse is performing a medication reconciliation. The resident's current medication regimen includes alfuzosin (Uroxatral).
 
  After considering the most likely indication for this drug, the nurse should include what potential problem in the resident's interdisciplinary plan of care? A) Impaired urinary elimination
  B) Ineffective sexual pattern
  C) Sexual dysfunction
  D) Functional urinary incontinence

Question 2

A patient with a diagnosis of active TB has begun second-line therapy that includes the use of pyrazinamide.
 
  When monitoring this patient, the nurse should suspect that adverse effects of this drug may account for which of the following laboratory values? A) Low hematocrit and mean corpuscular volume (MCV)
  B) Increased INR and aPTT
  C) Increased blood urea nitrogen and creatinine
  D) Increased AST, ALT, and GGT



bfulkerson77

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

A
Feedback:
Alfuzosin (Uroxatral) is classed as a nonreceptor subtype selective alpha1-adrenergic blocker also used to treat BPH. Impaired urinary elimination is the hallmark of BPH. Incontinence may result from BPH, but it is less commonly the functional subtype.

Answer to Question 2

D
Feedback:
The most severe adverse effect of pyrazinamide is hepatotoxicity. Consequently, liver enzymes such as GGT, ALT, and AST should be monitored. Changes in erythrocytes, coagulation, and renal function are less likely to result from pyrazinamide therapy.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

Did you know?

On average, the stomach produces 2 L of hydrochloric acid per day.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

For a complete list of videos, visit our video library